ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.675
      -0.13%
      Bitcoin
      65,278.66
      0.21%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Esperion Therapeutics Inc (ESPR)

      7. Esperion Therapeutics Inc (ESPR) News

      ESPR

      Esperion Therapeutics (ESPR)

      Esperion Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ESPR
      DateTimeSourceHeadlineSymbolCompany
      02/10/20231:47PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ESPREsperion Therapeutics Inc
      02/09/202311:48AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ESPREsperion Therapeutics Inc
      02/07/20231:07PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ESPREsperion Therapeutics Inc
      02/07/20238:00AMGlobeNewswire Inc.Esperion to Report Fourth Quarter and Full Year 2022 Financial Results February 21, 2023NASDAQ:ESPREsperion Therapeutics Inc
      01/20/20234:14PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ESPREsperion Therapeutics Inc
      01/11/202311:00AMGlobeNewswire Inc.RFK Announces Team-Wide Partnership with Esperion Therapeutics; Includes Primary Partnership for Brad Keselowski at the ’23 Daytona 500NASDAQ:ESPREsperion Therapeutics Inc
      01/08/20237:00PMGlobeNewswire Inc.Esperion Outlines Upcoming Milestones and Announces Preliminary Fourth Quarter 2022 Financial ResultsNASDAQ:ESPREsperion Therapeutics Inc
      01/04/20232:30PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ESPREsperion Therapeutics Inc
      12/19/20224:15PMGlobeNewswire Inc.CLEAR Outcomes Accepted as Late-Breaking Clinical Trial at ACC.23 Annual Scientific Session & Expo together with the World Congress of Cardiology (ACC.23/WCC)NASDAQ:ESPREsperion Therapeutics Inc
      12/13/20226:00PMGlobeNewswire Inc.Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ESPREsperion Therapeutics Inc
      12/13/20228:00AMGlobeNewswire Inc.Esperion to Participate in January Investor MeetingsNASDAQ:ESPREsperion Therapeutics Inc
      12/07/20222:15PMTipRanksNeedham Remains a Buy on Esperion (ESPR)NASDAQ:ESPREsperion Therapeutics Inc
      12/07/202211:15AMTipRanksJMP Securities Keeps Their Buy Rating on Esperion (ESPR)NASDAQ:ESPREsperion Therapeutics Inc
      12/07/202210:55AMTipRanksH.C. Wainwright Sticks to Their Buy Rating for Esperion (ESPR)NASDAQ:ESPREsperion Therapeutics Inc
      12/07/20228:05AMGlobeNewswire Inc.Esperion Announces CLEAR Cardiovascular Outcomes Trial of NEXLETOL® (bempedoic acid) Meets Primary EndpointNASDAQ:ESPREsperion Therapeutics Inc
      11/16/20224:09PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      11/16/20224:00PMGlobeNewswire Inc.Esperion Appoints Ben Halladay Chief Financial OfficerNASDAQ:ESPREsperion Therapeutics Inc
      11/10/20221:05PMTipRanksEsperion (ESPR) Gets a Buy from JMP SecuritiesNASDAQ:ESPREsperion Therapeutics Inc
      11/10/20226:25AMTipRanksEsperion (ESPR) Gets a Buy from H.C. WainwrightNASDAQ:ESPREsperion Therapeutics Inc
      11/09/20228:00AMGlobeNewswire Inc.Esperion Virtual Research & Development Day to Highlight Pipeline Programs and Scientific FocusNASDAQ:ESPREsperion Therapeutics Inc
      11/02/20228:05AMTipRanksEsperion (ESPR) Gets a Hold from J.P. MorganNASDAQ:ESPREsperion Therapeutics Inc
      11/02/20228:00AMGlobeNewswire Inc.Esperion to Participate in Jefferies London Healthcare ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      11/01/20223:25PMTipRanksNeedham Reaffirms Their Buy Rating on Esperion (ESPR)NASDAQ:ESPREsperion Therapeutics Inc
      11/01/202210:35AMTipRanksH.C. Wainwright Remains a Buy on Esperion (ESPR)NASDAQ:ESPREsperion Therapeutics Inc
      11/01/20228:54AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ESPREsperion Therapeutics Inc
      11/01/20227:24AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      11/01/20227:00AMGlobeNewswire Inc.Esperion Reports Third Quarter 2022 Financial Results and Provides Company UpdateNASDAQ:ESPREsperion Therapeutics Inc
      10/27/20228:00AMGlobeNewswire Inc.Esperion Hosting Virtual Research & Development DayNASDAQ:ESPREsperion Therapeutics Inc
      10/19/20224:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      10/19/20224:00PMGlobeNewswire Inc.Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ESPREsperion Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ESPR